Back to Search Start Over

Dynamic Alterations of Anti-S-Protein Igg Subclasses and of Th1/Th2 Responses are Hallmarks of Acute Severe COVID-19 Disease

Authors :
Yun Shan Goh
Pei Xiang Hor
Seow-Yen Tan
Siew-Wai Fong
Cheryl Yi-Pin Lee
Surinder Pada
Laurent Rénia
Yee Sin Leo
David C. Lye
Siti Naqiah Amrun
Mark I-Cheng Chen
Paul A. Tambyah
Barnaby Edward Young
Lisa Ng
Louisa Sun
Shirin Kalimuddin
Po Ying Chia
Publication Year :
2021
Publisher :
Research Square Platform LLC, 2021.

Abstract

PurposeCOVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), has a wide disease spectrum ranging from asymptomatic to severe. While it is widely accepted that specific humoral immune responses are critical in controlling the infection, the relationship between the humoral immune response and disease severity is currently unclear.MethodsUsing a flow cytometry-based assay to detect specific antibodies against full length S protein, we compared the antibody levels between patients from different severity groups. We also analysed the cytokine profiles of patients from different severity groups by multiplex microbead-based immunoassay.ResultsWe found an association between specific IgM, IgA and IgG against the spike protein and disease severity. By comparing the ratio of Th1 IgG1 and IgG3 to Th2 IgG2 and IgG4, we observed that all severity groups exhibited a ratio that was skewed towards a stronger Th1 response over Th2 response. In addition to the strong Th1 response, patients with severe disease also developed a Th2 response, as exemplified by the smaller ratio of IgG1 and IgG3 over IgG2 and IgG4 and the smaller Th1/Th2 cytokine ratios, compared to patients with mild disease severity. ConclusionThe results suggest that acute severity or disease resolution is associated with a specific immunological phenotype. A smaller skew towards a Th1 response over Th2 response, during infection, may contribute to disease progression, while a greater skew towards a Th1 response over Th2 response may contribute to a better disease outcome. This may suggest potential therapeutic approaches to COVID-19 disease management.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........90b6c53dd381c35aa9dbe67f943d51b6